Sunitinib-associated pseudothrombocytopenia induced by IgM antibody

References

• Chow LQ, Eckhardt SG. Sunitinib: From rational design to clinical efficacy. J Clin Oncol 2007; 25: 884–896
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe OR, Oudard S, Negrier S, Szczylik C, Kim ST, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356: 115–124
   PubMed Web of Science ®Google Scholar
• Bang YJ, Kang YK, Kang WK, Boku N, Chung HC, Chen JS, Doi T, Sun Y, Shen L, Qin S, et al. Phase II study of sunitinib as second-line treatment for advanced gastric cancer. Invest New Drugs 2011; 29: 1449–1458
   PubMed Web of Science ®Google Scholar
• van Erp NP, Mathijssen RH, van der Veldt AA, Haanen JB, Reyners AK, Eechoute K, Boven E, Wessels JA, Guchelaar HJ, Gelderblom H. Myelosuppression by sunitinib is flt-3 genotype dependent. Br J Cancer 2010; 103: 757–758
   PubMed Web of Science ®Google Scholar
• Pegels JG, Bruynes ECE, Engelfriet CP, Von dem borne AEGKR. Pseudothrombocytopenia: An immunologic study on platelet antibodies dependent on ethylen diamine tetra-acetate. Blood 1982; 59: 157–161
   PubMed Web of Science ®Google Scholar
• Onder O, Weinstein A, Hoyer LW. Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticougulated with chelating agents. Blood 1980; 56: 177–182
   PubMed Web of Science ®Google Scholar
• Zandecki M, Genevieve F, Gerard J, Godon A. Spurious counts and spurious results on haematology analysers: A review. Part I: Platelets. Int J Lab Hematol 2007; 29: 4–20
   PubMed Web of Science ®Google Scholar
• Cunningham VL, Brandt JT. Spurious thrombocytopenia due to EDTA-independent cold-reactive agglutinins. Am J Clin Pathol 1992; 97: 359–362
   PubMed Web of Science ®Google Scholar
• van Vliet HH, Kappers-Klunne MC, Abels J. Pseudothrombocytopenia: A cold autoantibody against platelet glycoprotein GPIIb. Br J Haematol 1986; 62: 501–511
   PubMed Web of Science ®Google Scholar
• Akbayram S, Dogan M, Akgun C, Caksen H, Oner AF. EDTA-dependent pseudothrombocytopenia in a child. Clin Appl Thromb Hemost 2011; 17: 494–496
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Yoshioka K, Hori A, Mukoyama K, Ohsawa A, Yokoh S. Cytomegalovirus mononucleosis with mixed cryoglobulinemia presenting transient pseudothrombocytopenia. Intern Med 1993; 32: 598–601
   PubMed Web of Science ®Google Scholar
• Lambertucci JR, Duani H, Prata PH, Voieta I. Pseudothrombocytopenia in schistosomiasis mansoni. Rev Soc Bras Med Trop 2011; 44: 792
   PubMed Web of Science ®Google Scholar
• Mori M, Kudo H, Yoshitake S, Ito K, Shinguu C, Noguchi T. Transient EDTA-dependent pseudothrombocytopenia in a patient with sepsis. Intensive Care Med 2000; 26: 218–220
   PubMed Web of Science ®Google Scholar
• Hoyt RH, Durie BG. Pseudothrombocytopenia induced by a monoclonal IgM kappa platelet agglutinin. Am J Hematol 1989; 31: 50–52
   PubMed Web of Science ®Google Scholar
• Irisawa A, Kaise S, Kumada Y, Sato Y, Nishimaki T, Kasukawa R, Moritoh T. A case of late-onset SLE complicated with EDTA-dependent pseudothrombocytopenia. Ryumachi 1992; 32: 468–74
   PubMedGoogle Scholar
• Wenzel F, Lasshofer R, Rox J, Fischer J, Giers G. Transient appearance of postoperative EDTA-dependent pseudothrombocytopenia in a patient after gastrectomy. Platelets 2011; 22: 72–74
   Web of Science ®Google Scholar
• Casonato A, Fabris F, Girolami A. Platelet aggregation and pseudothrombocytopenia induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease patient. Eur J Haematol 1990; 45: 36–42
   PubMed Web of Science ®Google Scholar
• Girmann G, Pees H, Scheurlen PG. Pseudothrombocytopenia and mexiletine. Ann Intern Med 1984; 100: 767
   PubMed Web of Science ®Google Scholar
• Kinoshita Y, Yamane T, Kamimoto A, Oku H, Iwata Y, Kobayashi T, Hino M. A case of pseudothrombocytopenia during antibiotic administration. Rinsho Byori 2004; 52: 120–123
   PubMedGoogle Scholar
• Kozak M, Dovc T, Rozman P, Blinc A. A case of pseudothrombocytopenia after infusion of abciximab in vivo and anticoagulant-independent platelet clumping after rechallenge with abciximab in vitro. Wien Klin Wochenschr 2000; 112: 138–141
   PubMed Web of Science ®Google Scholar
• Bizzaro N. EDTA-dependent pseudothrombocytopenia: A clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 1995; 50: 103–109
   PubMed Web of Science ®Google Scholar
• Sakurai S, Shiojima I, Tanigawa T, Nakahara K. Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia. Br J Haematol 1997; 99: 817–23
   PubMed Web of Science ®Google Scholar
• von dem Borne AEGKR, Verheugt FWA, Oosterhof F, von Riesz E, Brutel de la Riviere A, Engelfriet CP. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978; 39: 195–207
   PubMed Web of Science ®Google Scholar
• Kiefel V, Santoso S, Weisheit M. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet reactive antibodies. Blood 1987; 70: 1722–1726
   PubMed Web of Science ®Google Scholar
• De Caterina M, Fratellanza G, Grimaldi E, Varriale V, Scopacasa F, Di Maro G, Formisano S. Evidence of a cold immunoglobulin M autoantibody against 78-kD platelet glycoprotein in a case of EDTA-dependent pseudothrombocytopenia. Am J Clin Pathol 1993; 99: 163–167
   PubMed Web of Science ®Google Scholar
• Bizzaro N. Granulocyte aggregation is edetic acid and temperature dependent. Arch Pathol Lab Med 1993; 117: 528–530
   PubMed Web of Science ®Google Scholar
• Hillyer CD, Knopf AN, Berkman EM. EDTA-dependent leukoagglutination. Am J Clin Pathol 1990; 94: 458–461
   PubMed Web of Science ®Google Scholar
• Zhou X, Wu X, Deng W, Li J, Luo W. Amikacin can be added to blood to reduce the fall in platelet count. Am J Clin Pathol 2011; 136: 646–652
   PubMed Web of Science ®Google Scholar
• Ahn HL, Jo YI, Choi YS, Lee JY, Lee HW, Kim SR, Sim J, Lee W, Jin CJ. EDTA-dependent pseudothrombocytopenia confirmed by supplementation of kanamycin: A case report. Korean J Intern Med 2002; 17: 65–8
   PubMedGoogle Scholar
• Lombarts AJ, Zijlstra JJ, Peters RH, Thomasson CG, Franck PF. Accurate platelet counting in an insidious case of pseudothrombocytopenia. Clin Chem Lab Med 1999; 37: 1063–1064
   PubMed Web of Science ®Google Scholar
• Ocelik F, Arslan E, Sedar MA, Yiginer O, Oztosun M, Kayadibi H, Kurt I, A useful method for the detection of ethylenediaminetetraacetic acid- and cold agglutinin-dependent pseudothrombocytopenia. Am J Sci Med 2012 (Epub ahead of print)
   Google Scholar
• Berkman N, Michaeli Y, Or R, Eldor A. EDTA-dependent pseudothrombocytopenia: A clinical study of 18 patients and review of the literature. Am J Hematol 1991; 36: 195–201
   PubMed Web of Science ®Google Scholar
• Solanki DL, Blackburn BC. Spurious leukocytosis and thrombocytopenia: A dual phenomenon caused by clumping of platelets in vitro. JAMA 1983; 250: 2514–2515
   PubMed Web of Science ®Google Scholar
• Sharma A, Pinto Pereira LM, Capildeo K, Charles K, Teelucksingh S. Steroid-induced iatrogenic disease after treating for pseudothrombocytopenia. Clin Appl Thromb Hemost 2011; 17: 100–102
   PubMed Web of Science ®Google Scholar
• Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Eng J Med 2007; 357: 580–587
   PubMed Web of Science ®Google Scholar
• Bougie DW, Aster RH. Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen. Blood 2011; 97: 3846–3850
   Google Scholar